{
  "cik": 1635088,
  "cik_padded": "0001635088",
  "entityName": "Roivant Sciences Ltd.",
  "fiscal_years": [
    {
      "accn": "0001635088-26-000061",
      "filed": "2026-05-20",
      "fiscal_year": 2026,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8209000.0,
        "cash": 1419232000.0,
        "eps_diluted": -0.54,
        "free_cash_flow": -758558000.0,
        "net_income": -299771000.0,
        "operating_cash_flow": -750349000.0,
        "operating_income": -515068000.0,
        "revenue": 8260000.0,
        "stockholders_equity": 4527370000.0,
        "total_assets": 5708687000.0,
        "total_liabilities": 416275000.0
      },
      "period_end": "2026-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09194631761928007,
        "revenue_growth_yoy": -0.7156920111520325,
        "roa_avg2y": -0.053791679911771674,
        "roa_period_end": -0.052511374331785925,
        "roe_avg2y": -0.06506170662427191,
        "roe_period_end": -0.06621305526166406
      }
    },
    {
      "accn": "0001635088-26-000061",
      "filed": "2026-05-20",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 1293232000.0,
        "capex": 4599000.0,
        "cash": 2715411000.0,
        "eps_diluted": -0.24,
        "free_cash_flow": -844050000.0,
        "net_income": -171981000.0,
        "operating_cash_flow": -839451000.0,
        "operating_income": -1003294000.0,
        "revenue": 29053000.0,
        "stockholders_equity": 4687605000.0,
        "total_assets": 5436940000.0,
        "total_liabilities": 249742000.0
      },
      "period_end": "2025-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05327709992629499,
        "roa_avg2y": -0.02717043479552226,
        "roa_period_end": -0.03163194738216717,
        "roe_avg2y": -0.03227815280251302,
        "roe_period_end": -0.036688458178536804
      }
    },
    {
      "accn": "0001635088-26-000061",
      "filed": "2026-05-20",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 1382000.0,
        "cash": 6494953000.0,
        "eps_diluted": 5.23,
        "free_cash_flow": -766650000.0,
        "net_income": 4348926000.0,
        "operating_cash_flow": -765268000.0,
        "operating_income": 4497032000.0,
        "stockholders_equity": 5968581000.0,
        "total_assets": 7222482000.0,
        "total_liabilities": 773953000.0
      },
      "period_end": "2024-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1296711898523284,
        "roa_avg2y": 0.9048870349266538,
        "roa_period_end": 0.6021373261989438,
        "roe_avg2y": 1.2205204152983289,
        "roe_period_end": 0.72863650505874
      }
    },
    {
      "accn": "0001140361-25-020715",
      "filed": "2025-05-29",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 12690000.0,
        "cash": 1676813000.0,
        "eps_diluted": -1.42,
        "free_cash_flow": -856083000.0,
        "net_income": -1009030000.0,
        "operating_cash_flow": -843393000.0,
        "operating_income": -906763000.0,
        "revenue": 31530000.0,
        "stockholders_equity": 1157766000.0,
        "total_assets": 2389604000.0,
        "total_liabilities": 782017000.0
      },
      "period_end": "2023-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.6754534163207419,
        "revenue_growth_yoy": -0.4296928698042904,
        "roa_avg2y": -0.40566197221036787,
        "roa_period_end": -0.42225824864705624,
        "roe_avg2y": -0.7169690660849608,
        "roe_period_end": -0.8715318985010788
      }
    },
    {
      "accn": "0001140361-23-031798",
      "filed": "2023-06-28",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 17436000.0,
        "cash": 2060400000.0,
        "eps_diluted": -1.26,
        "free_cash_flow": -695165000.0,
        "net_income": -845262000.0,
        "operating_cash_flow": -677729000.0,
        "operating_income": -1351642000.0,
        "revenue": 55286000.0,
        "stockholders_equity": 1656944000.0,
        "total_assets": 2585129000.0,
        "total_liabilities": 523695000.0
      },
      "period_end": "2022-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.31606077212024064,
        "revenue_growth_yoy": 1.3234292918680395,
        "roa_avg2y": -0.32668260409393873,
        "roa_period_end": -0.3269709171186428,
        "roe_avg2y": -0.4893357863938505,
        "roe_period_end": -0.5101331125252272
      }
    },
    {
      "accn": "0001193125-22-183362",
      "filed": "2022-06-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5806000.0,
        "cash": 2055044000.0,
        "free_cash_flow": -557944000.0,
        "net_income": -809234000.0,
        "operating_cash_flow": -552138000.0,
        "operating_income": -1070898000.0,
        "revenue": 23795000.0,
        "stockholders_equity": 1797788000.0,
        "total_assets": 2589692000.0,
        "total_liabilities": 527687000.0
      },
      "period_end": "2021-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.29352014809310106,
        "roa_period_end": -0.31248271995279747,
        "roe_period_end": -0.45012760125220547
      }
    }
  ],
  "latest_filing": {
    "accn": "0001635088-26-000061",
    "filed": "2026-05-20",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001635088.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001635088.json"
  },
  "ticker": "ROIV"
}